The much-awaited remedy to the widespread transmission of SARS-CoV-2 comes with many logistical caveats.
A total of 131 cases of COVID-19 were reported in the interim analysis, with no hospitalizations or severe cases noted in participants who received the vaccine.
The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.
The trial will continue as planned and final analysis is expected when the number of confirmed COVID-19 cases reaches 164.
Nurse practitioners (NPs) executed a 5-step vaccination program for homeless individuals in Miami-Dade County to help reduce the spread of infectious diseases.
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
The 2018 to 2019 influenza vaccine effectiveness was about 40% to 60% for reducing pediatric influenza A-associated hospitalizations.
The trial is investigating the efficacy, safety, and immunogenicity of mRNA-1273 at the 100mcg dose.
Results from PNEU-PATH demonstrated comparable immune responses following vaccination with Pneumovax 23 in both treatment groups for the 15 serotypes in V114.
To estimate the association between attribute level and probability of choosing and receiving a vaccine, the study authors calculated the average marginal component effects sizes as well as marginal means.
One-third of parents say they will forgo the flu vaccination for their children this year, despite public health recommendations.
Diphenhydramine when taken at higher than recommended doses can lead to serious health complications.
Routine vaccination with a quadrivalent meningococcal conjugate vaccine is recommended for adolescents aged 11 to 12 years.
The Medicines Health Regulatory Authority confirmed that the AZD1222 trial could proceed after a UK committee concluded its investigations.
Single-dose nirsevimab successfully reduced rates of respiratory syncytial virus-associated lower respiratory infections and hospitalizations in pre-term infants.
An investigational inactivated whole-virus COVID-19 vaccine has demonstrated safety and immunogenicity, according to an interim analysis.
Influenza vaccinations were found to be underutilized among groups who are considered to be at high risk for complications from infection.
Influenza vaccination should occur by the end of October, if possible.
HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
Most pediatric practitioners do not counsel families to wait 3 days or longer between introducing new foods for infants.